Celldex Therapeutics shares owned by Royal Bank of Canada
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Royal Bank of Canada
from 13F filings
Historical chart of Royal Bank of Canada investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Celldex Therapeutics by Royal Bank of Canada
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $264k | 7.8k | 34.08 |
2024-06-30 | $241k | 6.6k | 36.36 |
2024-03-31 | $78k | 1.9k | 41.75 |
2023-12-31 | $595k | 15k | 39.68 |
2023-09-30 | $211k | 7.8k | 27.14 |
2023-06-30 | $170k | 5.0k | 33.87 |
2022-12-31 | $226k | 5.4k | 41.92 |
2022-09-30 | $17k | 593 | 29.41 |
2021-06-30 | $90k | 2.7k | 33.53 |
2020-12-31 | $4.0k | 245 | 16.33 |
2020-09-30 | $0 | 13 | 0.00 |
2020-06-30 | $3.2k | 272 | 11.58 |
2020-03-31 | $2.0k | 1.4k | 1.41 |
2019-12-31 | $1.0k | 485 | 2.12 |
2019-09-30 | $1.0k | 569 | 1.80 |
2019-03-31 | $0 | 13 | 0.00 |